NBL1 Correlates with Kidney Disease in a Mouse Model for Alport Syndrome, but Is Not Causal

被引：0
|
作者：
Willey, Courtney [1 ,2 ]
Bufi, Rei [1 ]
Brackett, Abigail [1 ]
Sheehan, Susan Marie [1 ]
Korstanje, Ron [1 ,2 ]
机构：
[1] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA
[2] Univ Maine, Orono, ME USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024rg098x15
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO613
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Kidney Protection by a Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor for a Mouse Model of Alport Syndrome
    Horizono, Jun
    Kaseda, Shota
    Sannomiya, Yuya
    Suico, Mary Ann
    Fukiya, Hirohiko
    Sunamoto, Hidetoshi
    Watanabe, Hiroshi
    Nakano, Takehiro
    Tokumaru, Kai
    Davenport, John Bernard
    John, Bernard
    Shuto, Tsuyoshi
    Lennon, Rachel
    Onuma, Kazuhiro
    Kai, Hirofumi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [22] Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome
    Bada-Bosch, Teresa
    Sevillano, Angel M.
    Sanchez-Calvin, Maria Teresa
    Palma-Milla, Carmen
    de Caceres, Ignacio Alba
    Diaz-Crespo, Francisco
    Trujillo, Hernando
    Alonso, Marina
    Cases-Corona, Clara
    Shabaka, Amir
    Quesada-Espinosa, Juan Francisco
    Lezana-Rosales, Jose Miguel
    Gutierrez, Eduardo
    Fernandez-Juarez, Gema
    Caravaca-Fontan, Fernando
    Praga, Manuel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (08) : 1288 - 1298
  • [23] A Case of Mistaken Identity: Alport Syndrome Masquerading as Polycystic Kidney Disease
    Amari, Kana R.
    Tuazon, Jennifer A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 412 - 412
  • [24] Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea
    Matsumura, Takuma
    Terada, Jiro
    Kinoshita, Taku
    Sakurai, Yoriko
    Yahaba, Misuzu
    Tsushima, Kenji
    Sakao, Seiichiro
    Nagashima, Kengo
    Ozaki, Toshinori
    Kobayashi, Yoshio
    Hiwasa, Takaki
    Tatsumi, Koichiro
    PLOS ONE, 2018, 13 (03):
  • [25] Kidney disease progression and risk factors in pregnant women with Alport syndrome
    Kong, Xinxin
    Wang, Fang
    Shi, Chunyan
    Zhang, Hongwen
    Ding, Jie
    Zhang, Yanqin
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2443 - 2443
  • [26] CYSTIC KIDNEY DISEASE IN ALPORT SYNDROME: ONE NEPHROLOGY CENTER DATA
    Aksenova, Marina
    Konkova, Natalia
    Dobrynina, Marina
    Chumak, Olga
    PEDIATRIC NEPHROLOGY, 2022, 37 (11) : 2826 - 2826
  • [27] PPARd Agonism Ameliorates Renal Fibrosis in an Alport Syndrome Mouse Model
    Omachi, Kohei
    O'Carroll, Colin
    Miner, Jeffrey H.
    KIDNEY360, 2023, 4 (03): : 341 - 348
  • [28] Metformin ameliorates progressive nephritis in a mouse model of Alport syndrome.
    Kaseda, S.
    Omachi, K.
    Yokota, T.
    Kuwazuru, J.
    Kamura, M.
    Teramoto, K.
    Kojima, H.
    Suico, M.
    Shuto, T.
    Otsuki, S.
    Kai, H.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [29] Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome
    Liu, Xiaochen
    Ducasa, Gloria Michelle
    Mallela, Shamroop Kumar
    Kim, Jin-Ju
    Molina, Judith
    Mitrofanova, Alla
    Wilbon, Sydney Symone
    Ge, Mengyuan
    Fontanella, Antonio
    Pedigo, Christopher
    Santos, Javier Varona
    Nelson, Robert G.
    Drexler, Yelena
    Contreras, Gabriel
    Al-Ali, Hassan
    Merscher, Sandra
    Fornoni, Alessia
    KIDNEY INTERNATIONAL, 2020, 98 (05) : 1275 - 1285
  • [30] PREDICTORS OF KIDNEY DISEASE PROGRESSION IN MALES WITH X-LINKED ALPORT SYNDROME
    Aksenova, Marina
    Zaikova, Natalia
    Piruzeeva, Oxana
    Lepaeva, Tatjana
    Obuhova, Varvara
    Nikishina, Tatjana
    Konkova, Natalia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I476 - I476
12345